We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 93.50
Bid: 92.00
Ask: 95.00
Change: 0.00 (0.00%)
Spread: 3.00 (3.261%)
Open: 93.50
High: 93.50
Low: 93.50
Prev. Close: 93.50
MVI Live PriceLast checked at -
Marwyn Value Investors is an Investment Trust

To achieve long-term capital appreciation through its investment in the Master Fund primarily by focusing in mid cap businesses headquartered in the UK, Europe or North America.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

22 Sep 2020 07:00

RNS Number : 6401Z
Marwyn Value Investors Limited
22 September 2020
 

LEI: 213800L5751QTTVEA774

 

22 September 2020

 

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

 

PURCHASE OF ORDINARY SHARES

 

PURCHASE OF ORDINARY SHARES

The Company announces that Liberum Capital Limited as broker, on behalf of Marwyn Value Investors L.P. (the "Master Fund"), has purchased 9,471 of the Company's ordinary shares ("Ordinary Shares") (the "Purchased Shares").

 

Date of transaction:

21 September 2020

Average price paid per Ordinary Share:

111.0000 pence

Lowest price paid per Ordinary Share:

111.0000 pence

Highest price paid per Ordinary Share:

111.0000 pence

 

The total number of the Company's Ordinary Shares owned by, or on behalf of, the Master Fund in respect of the Company's buyback programme is 2,071,904. The Company has been informed that the Master Fund intends to utilise the Exchange Procedure (as defined and described in the Company's prospectus dated 19 October 2016) in respect of the Purchased Shares such that the Purchased Shares will, in due course, be cancelled.

Until the Exchange Procedure is utilised in respect of any Ordinary Shares, the total number of voting rights in the Company remains as 63,668,685 comprising 59,481,459 Ordinary Shares and 4,187,226 Realisation Shares, each carrying one vote per share. These figures should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For the purposes of the weekly estimated net asset value per Ordinary Share reporting, the Company will treat the Purchased Shares as already cancelled.

 

SHARE ACQUISITION BY MARWYN LONG TERM INCENTIVE LP

The Company today announces that it was notified that on 21 September 2020, Marwyn Long Term Incentive LP ("MLTI") purchased 6,029 Ordinary Shares in the Company, all at a price of 111.0000 pence per share. 

MLTI, Mark Brangstrup Watts, James Corsellis and Antoinette Vanderpuije, now together hold 9,883,716 Ordinary Shares, representing approximately 16.62% of the Company's issued Ordinary Shares.

 

MLTI is a Person Closely Associated with Mark Brangstrup Watts, James Corsellis and Antoinette Vanderpuije, all directors of Marwyn Asset Management Limited ("MAML"), the manager of the Company and Marwyn Value Investors LP. Whilst none of Mark Brangstrup Watts, James Corsellis and Antoinette Vanderpuije are PDMRs, they are voluntarily disclosing today's information to the market on an aggregate basis as if they were.

As announced on 27 May 2020 (Completion of Amended Accelerated Bookbuild), following completion of those transactions, MLTI is required to use the remaining proceeds from the Net Cash Amount (as defined in the announcement) of approximately £1.6 million to purchase Ordinary Shares alongside MVI LP as part of the Company's buyback programme. Following this transaction, MLTI has £306,932 remaining before commission and stamp duty to purchase Ordinary Shares.

 

Company enquiries:

 

Louisa Bonney / Scott Danks

Axio Capital Solutions Limited

Telephone: 01534 761240

 

Gillian Martin

Liberum Capital Limited

Telephone: 020 3100 2200

 

PR enquiries:

 

Alex Child-Villiers / Will Barker

Temple Bar Advisory

Telephone: 020 7975 1415

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQFLFLBKLXBBZ
Date   Source Headline
26th Apr 20225:43 pmRNSNet Asset Value – Ordinary Shares
21st Apr 202211:02 amRNSNotification of major interests in shares
21st Apr 202211:01 amRNSNotification of major interests in shares
20th Apr 20225:52 pmRNSShare Transfer
13th Apr 20221:04 pmRNSNet Asset Value – 2021 Realisation Shares
13th Apr 20221:01 pmRNSNet Asset Value – 2016 Realisation Shares
13th Apr 20221:00 pmRNSNet Asset Value – Ordinary Shares
1st Apr 202212:14 pmRNSNet Asset Value – 2021 Realisation Shares
1st Apr 202212:12 pmRNSNet Asset Value – 2016 Realisation Shares
1st Apr 202212:11 pmRNSNet Asset Value - Ordinary Shares
25th Mar 202212:37 pmRNSNet Asset Value - 2021 Realisation Shares
25th Mar 202212:34 pmRNSNet Asset Value - 2016 Realisation Shares
25th Mar 202212:31 pmRNSNet Asset Value - Ordinary Shares
14th Mar 20221:48 pmRNSNet Asset Value - 2021 Realisation Shares
14th Mar 20221:46 pmRNSNet Asset Value - 2016 Realisation Shares
14th Mar 20221:44 pmRNSNet Asset Value - Ordinary Shares
4th Mar 202210:21 amRNSNet Asset Value - 2021 Realisation Shares
4th Mar 202210:17 amRNSNet Asset Value - 2016 Realisation Shares
4th Mar 202210:14 amRNSNet Asset Value - Ordinary Shares
25th Feb 202211:18 amRNSNet Asset Value - 2021 Realisation Shares
25th Feb 202211:14 amRNSNet Asset Value - 2016 Realisation Shares
25th Feb 202211:10 amRNSNet Asset Value - Ordinary Shares
11th Feb 202210:16 amRNSNet Asset Value - 2021 Realisation Shares
11th Feb 202210:12 amRNSNet Asset Value - 2016 Realisation Shares
11th Feb 202210:04 amRNSNet Asset Value - Ordinary Shares
4th Feb 202212:07 pmRNSNet Asset Value - 2021 Realisation Shares
4th Feb 202212:04 pmRNSNet Asset Value - 2016 Realisation Shares
4th Feb 202212:02 pmRNSNet Asset Value - Ordinary Shares
28th Jan 202212:37 pmRNSNet Asset Value - 2021 Realisation Shares
28th Jan 202212:36 pmRNSNet Asset Value - 2016 Realisation Shares
28th Jan 202212:35 pmRNSNet Asset Value - Ordinary Shares
27th Jan 20227:00 amRNSInterim Dividend to Ordinary Shareholders
17th Jan 20222:43 pmRNSNet Asset Value - 2021 Realisation Shares
17th Jan 20222:39 pmRNSNet Asset Value - 2016 Realisation Shares
17th Jan 20222:35 pmRNSNet Asset Value - Ordinary Shares
7th Jan 20222:48 pmRNSAdvancedAdvT Potential Merger
30th Dec 202111:56 amRNSNet Asset Value - 2021 Realisation Shares
30th Dec 202111:55 amRNSNet Asset Value - 2016 Realisation Shares
30th Dec 202111:52 amRNSNet Asset Value - Ordinary Shares
24th Dec 20218:07 amRNSLaunch of MAC Alpha Limited
23rd Dec 20219:04 amRNSNet Asset Value - 2021 Realisation Shares
23rd Dec 20219:02 amRNSNet Asset Value - 2016 Realisation Shares
23rd Dec 20219:00 amRNSNet Asset Value - Ordinary Shares
14th Dec 202111:46 amRNSResult of AGM
13th Dec 20215:07 pmRNSNet Asset Value – 2021 Realisation Shares
13th Dec 20215:04 pmRNSNet Asset Value – 2016 Realisation Shares
13th Dec 20215:01 pmRNSNet Asset Value – Ordinary Shares
3rd Dec 20219:31 amRNSNet Asset Value
3rd Dec 20219:29 amRNSNet Asset Value
30th Nov 20217:00 amRNSAdmission of 2021 Realisation Shares to the SFS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.